Meridiem Capital Partners LP
Position in CRL — Charles River Laboratories International, Inc.
CIK 2026798
DALLAS, TX
Position in CRL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$62,461,905
+$35,954,405 QoQ
Shares Held
362,098
+172.5% QoQ
Ownership
0.752%
of shares outstanding
% of Portfolio
4.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Meridiem Capital Partners LP holds $214,886,909 across 8 Diagnostics & Research names. CRL ranks #1 (29.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
This page
|
362,098 | $62,461,905 | |
| 2 | WAT |
Waters Corp /De/
|
207,814 | $61,887,009 | |
| 3 | ILMN |
Illumina, Inc.
|
313,272 | $38,613,906 | |
| 4 | A |
Agilent Technologies, Inc.
|
184,897 | $21,074,560 | |
| 5 | TWST |
Twist Bioscience Corp
|
239,669 | $11,389,070 | |
| 6 | ICLR |
Icon PLC
|
93,878 | $10,388,539 | |
| 7 | CDNA |
CareDx, Inc.
|
316,950 | $5,502,252 | |
| 8 | WGS |
GeneDx Holdings Corp.
|
55,585 | $3,569,668 |
All Filings in CRL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $62,461,905 | 362,098 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $26,507,500 | 132,883 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,025,266 | 70,467 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $18,212,758 | 120,034 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||